Digestive System TRIZ Cases

Adding solid carriers like sugars to liquid Pelargonium extracts reduces solvent content and improves solubility for pharmaceutical processing.

Dihydro-lipoic acid neutralizes hydrogen peroxide to reverse mitochondrial DNA oxidative damage, avoiding immunosuppressive side effects.

A thiazolidinedione derivative compound treats fatty liver disease by modulating lipid metabolism and reducing liver damage indicators.

Anti-HLA-DQ2.5/8 antibodies bind to specific molecules and block interaction with T cells despite unintentional gluten contamination.

Aprotic solvent modulates polyorthoester release kinetics, tailoring drug delivery profiles from rapid onset to sustained action over weeks.

Fully human antibodies bind CD147 epitopes with high affinity using optimized variable region sequences to treat CD147-expressing tumors.

Tri-substituted starch esters incorporate acetate, propionate, and butyrate linkages to enhance microbial SCFA production without DMSO solvents.

NP137 neutralizes netrin-1 to reduce hepatic inflammation and fibrogenesis while preserving hepatocyte survival.

Clostridiales probiotics restore gut flora balance, reducing bloating and cramping from cruciferous vegetables.

Monofunctional aldehydes form separable aldehyde-bisulfite complexes, removing bisulfite while preserving catalytic activity under neutral conditions.

Osmotic stress and flow shear remove cells while preserving extracellular matrix integrity for disease modeling.

IL22RA2 gene locus replaces invasive liver biopsy with genetic testing to predict fibrosis progression and optimize antiviral treatment selection.

Cyclic peptides activate the Guanylate Cyclase C receptor to enhance fluid secretion, resolving patient intolerance issues in colon preparation.

Sangivamycin analogs bind Ebola VP40 proteins to block viral particle assembly, preventing infectious virion formation.

An intermittent flow extrusion process creates composite pet treats with a bone-like inner core and meaty outer shell.

DPP-4 inhibitors treat non-alcoholic fatty liver disease by modulating endogenous GLP-1 levels to enhance insulin secretion.

A Pediococcus-based probiotic composition restores gut microbiota balance and enhances immune response in mammals.

A macroporous biomaterial scaffold supports tissue regeneration through physical crosslinking and lyophilization.

Optimized fully human anti-CD137 antibodies resolve specificity and affinity trade-offs to enhance T cell activation.

TNP purine inhibits JNK phosphorylation to prevent acetaminophen-induced liver toxicity.

Tangential flow filtration isolates active fractions from Graptopetalum paraguayense extracts using ultrafiltration membranes.

A bispecific antibody links FolR1-expressing tumor cells to CD3 on T cells to drive localized immune activation.

Recombinant albumin conjugates bind specifically to Cysteine 34 via cleavable linkers for targeted delivery.

An inverted heat exchanger arrangement eliminates separator units to reduce pressure loss and protect equipment from contamination.

Replacing terminal methyl groups with carborane clusters reduces cardiovascular difficulties while maintaining effective muscle relaxation.

A cervical stem cell secretome composition promotes dental pulp proliferation and root tissue regeneration.

Three-stage fermentation of Actinidia chinensis Planch extract boosts superoxide dismutase activity to resolve functional dyspepsia.

Formaldehyde scavenger compounds protect linaclotide from degradation, maintaining pharmaceutical efficacy during storage.

A sphingolipid compound specifically targets the S1P4 receptor to inhibit inflammatory cell infiltration in liver tissue.

Optimized antibody CDRs increase binding affinity to neutralize IL-33, reducing dosage requirements for treating atopic dermatitis.

Flt3-ligand expands CD8+ conventional dendritic cells to produce interferon-lambda, resolving unclear cellular origins of antiviral responses.

Oral capsules deliver lyophilized fecal filtrate to modulate gut microbiota while eliminating pathogen transmission risks from invasive procedures.

Blood betaig-h3 analysis detects early tumor stroma changes, addressing the lack of reliable diagnostic biomarkers for pancreatic ductal adenocarcinoma.

Vitamin E TPGS surfactant maintains Compound 1 solubility, enabling oral administration for patients unable to swallow solid dosage forms.

Conjugating anti-ASGR1 antibodies with TLR8 agonists targets liver cells, resolving viral immune evasion while preventing systemic liver damage.

A three-strain probiotic combination increases beneficial bacteria and short-chain fatty acids in the gut.

Spray layering preserves antibody activity and enables sustained gastrointestinal release profiles.

Multilayered microparticles protect acid-labile compounds from gastric degradation using an enteric layer and a hydrophobic outer shell.

GC-C agonist peptides activate guanylate cyclase receptors to alleviate opioid-induced bowel dysfunction through enhanced fluid secretion.

Segmented unit-dose syringes eliminate manual measurement steps, accelerating emergency treatment while maintaining formulation stability.

Blocking the CCL28 chemotactic pathway reduces regulatory T cell infiltration, overcoming immune escape mechanisms that limit gastric cancer treatment efficacy.

Antibodies bind tumor-associated carbohydrate antigens to identify cancer cells, resolving the trade-off between detection coverage and development complexity.

High micropore volume activated carbon adsorbs toxins while maintaining mechanical stability for medical use.

Cornelian cherry seed extract inhibits pathogens and improves weight gain without antibiotic resistance.

Assessing GPC3-targeting drug efficacy via free receptor levels resolves low objective response rates and adverse reactions from conventional chemotherapy.

Monoclonal antibodies target the Norovirus VP1 polypeptide to reduce viral titer, addressing the lack of effective antiviral therapies and diagnostic tools.

A solid dosage formulation combines intra-granular osmotic agents with extra-granular organic acids to drive colonic evacuation.